FILIP1L and ovarian carcinoma: A recent study had shown that down-regulated expression of FILIP1L is related to the invasive phenotype in ovarian tumor, indicating that FILIP1L has the potential to be a biomarker for invasive potential and a target for novel ovarian cancer therapy [3].